MVJ Medical College And Research Hospital Integrated and Aligned Time table Block -2 Teaching Program - Theory, Practicals Block - 2 01/07/2021 to 30/09/2021 8.30 - Time 11.30 - 12.30 12.30 - 1.30 1.30 - 2.00 2.00 - 4.00 2 TO 3 3 TO 4 4 TO 5 11.30 Lecture/ SGD Date Day clinicals Lecture/SGD class lunch Practicals /SGD/SDL OBG AETCOM SDL SPRTS /ECA class

Microbiology Pathology Pharmacology Community Medicine SPORTS /ECA

PA18.2 Acute PH 1.20 - Alcohol PH CM 1 PQLI, HDI calculation 1/7/21 THURS Leukemia (L) 1.23 - Drug Deaddiction (L) SGD Ph.1.24.1 physiology of Nephron MI3.1.1 (LECTURE ((SGD 1 )MI3.1.2 01) Introduction to Diarrheagenic E.coli PA 18.1 Non Leukemic 2/7/21 FRI gastrointestinal PA18.2 Chronic Leukemia (L) MI3.1.5 Viral Leucocyte disoreder Pandemic 2.4 infections diarhhea (SGD)

IM22.1:- Enumerate the causes of hpercalcemia and distinguish the features of PTH us non PTH mediated hypercalcemia. IM22.2:- Describe the OG14.1 Maternal SU5.1 - Describe normal wound actiology, clinical pelvis: Diameters 3/7/21 SAT healing and factors affecting AETCOM2.4 manifestations, (Clinical pelvimetry healing diagnosis and clinical & Types of pelvis) approach to primary hyperthroidism. IM22.3:- Describe the approach to the management to ypercalcemia 4/7/21 SUN MI3.1.2 ,3,5 AE -3(BATCH A) Diarrheagenic E.coli, cholera,food PH 1.19.58 - 1.19.65 - PA 19.4 Hodgkins Lymphoma & poisoning Hanging drop preperation 5/7/21 MON NEURODEGENERATIVE PA 14 15 MHA & Dimorphic ( Pracs B) MICRO SDL Non Hodgkins Lymphoma (L) MI3.1.7 ,8,9 DOAP: Stool examination DISORDERS (SGD) (3,4,5); Demonstration - EnatamoebaGiardia,Coccidia MI3.1.6 AE MI3.1.3 MI3.1.2 ,3,5 AE -3(BATCH B) 6/7/21 TUE (LECTURE PH 1.24 - DIURETICS (L) Diarrheagenic E.coli, cholera,food PH 3.7 ESSENTIAL DRUGS - Batch A PATHO SDL 02)Cholera poisoning Hanging drop preperation MI3.1.6 (LECTUR MI3.1.7 ,8,9 DOAP: Stool examination CM 1 Concepts of 7/7/21 WED 03)Bacillary dysentery PA 14 15 MHA & Dimorphic ( Pracs A) PH 3.7 ESSENTIAL DRUGS - Batch B COM MED SDL health PA21.1 Normal 8/7/21 THURS Hemostasis & PH 1.24 - DIURETICS (L) CM 1 PQLI, HDI calculation SGD SPORTS /ECA Haemophilia (L) MI3.1.7 (LECTURE MI3.1.9 (SGD 2) 04)Parasitic dysentery Soil transmitted PA21.2 Vascular & Platelet PA 13 Formative 9/7/21 FRI E.histolytica helminthic infections Pandemic 2.4 Disorders (L) assesment (SGD) Balantidium coli MI 3.6 Overview of Acid peptic disorder IM22.4:- Enumerate the components and describe the genetic basis of the multiple endocrine neoplasia syndrome. IM22.5:Enumerate the casuses and describe the clinical features and the OG9.1 Etiology and correct approach to the management of SU5.2 - Elicit, document and diagnosis and abortions including present a history in a patient 10/7/21 SAT menagement of the threatened, AETCOM 2.4 presenting with patint with wounds. incomplete, hyponatremia. inevitable, missed IM22.6:Enumerate the and septic. causes and describe the clinical and laboratory feature and the correct approach to the diagnosis and managment of the patient with hyponatremia. 11/7/21 SUN PH 1.27.1 - 1.27.2 MI3.4 AE (BATCH A)–Lab diagnosis of CATEGORIES OF HTN-JNC PA 21.4 21.5 DIC & Vit K Deficiency Enteric fever 1st week- blood culture 12/7/21 MON 7&8, & PA 16.6 Hemolytic Anemia ( Pracs B) SPORTS /ECA (L) 2nd week widal test PATHOPHYSIOLOGY OF HTN (SGD) MI3.1.8(lecture MI3.4 AE (BATCH B)–Lab diagnosis of 05)Parasitic Diarrhea Enteric fever 1st week- blood culture in immunocompetent PH 1.24.11 - 1.24.17 2nd week widal test 13/7/21 TUE and ANTIDIURETICS & VASOPRESSIN PH 3.7 ESSENTIAL DRUGS - Batch A PATHO SDL immunocompromised ANALOGUES (L)

MI3.3(lecture 06) Enteric 14/7/21 WED CM 2 Social health PA 16.6 Hemolytic Anemia ( Pracs A) PH 3.7 ESSENTIAL DRUGS - Batch B fever PH 1.26.1-1.26.2 - RAAS PA22.4 22.5 Blood Components & PH 1.26 - DRUGS ACTING ON RAAS 15/7/21 THURS Transfusion CM 1 Health Indicators SGD MICRO SDL (L) transmitted Infections (L) MI3.5 (lecture 07) MI 3.7. Food poisoning 1(LECTURE 08) PA 22.6 22.7 Transfusion Enterically PA 8.1 Role of 16/7/21 FRI reactions & Autologous Pandemic 2.4 transmitted Viral cytology (SGD) transfusions (L) hepatitis - Hepatitis A and E 17/7/21 SAT 18/7/21 SUN MI3.7 AE : (Batch A) Seromarkers of PH 1.27.17 - 1.27.22 Hepatitis B, Hepatitis C 19/7/21 MON TREATMENT OF SHOCK PA11.1 Genetic Disorders (L) PA 18 Leukemia ( Pracs B) COM MED SDL (SGD)

MI 3.7. 2 -(lecture MI3.7 AE : (Batch B) Seromarkers of PH 1.27.6 - 1.27.12 CALCIUM 09) Hepatitis B Hepatitis B, Hepatitis C 20/7/21 TUE CHANNEL BLOCKER & PH 3.5 P drugs- Batch A VASODILATORS (L)

CM 3 Nutrition MI 3.7. 3 (Lecture 10) 21/7/21 WED PA 18 Leukemia ( Pracs B) PH 3.5 P drugs - Batch B PATHO SDL and health into Hepatitis C and D

PA 11.2 Tumors of PH 1.27.10 - 1.27.13 - 1.27.16 CM 2 IEC and Behavioural change 22/7/21 THURS infancy & childhood TREATMENT OF HTN & HTN communication (BCC) - concept MICRO SDL (L) EMERGENCIES (L) and examples SGD

MI4.1.1: (Lecture MI4.1.6 (SGD 3) PA 8.2 PAP smear & 23/7/21 FRI 11) Introduction to PA11.3 Storage disorders (L) Actinomycosis, Pandemic 2.4 anaerobic infections. Nocardia. Body Fluids (SGD) MI4.3.7 Cellulitis IM22.7:-Enumerate the causes and describe the clinical and laboratory features and the correct approach to the diagnosis and managment of the patient with hypokalemia IM22.8:Enumerate the SU5.3 - Differentiate the various causes and describe types of wounds, plan and OG9.5 Hyperemesis 24/7/21 SAT the clinical and AETCOM2.5 observe gravidarum laboratory featuress management of wounds and the correct approch to the diagnosis and management of the patient with hyperkalemia. IM22.9:Enumetate the causes and describe the clinical and laboratory features of metabolic acidosis.

25/7/21 SUN

PH 1.28.1 - 1.28.2, (Batch A) Applied bacteriology, virology PA 19 Specimen - Spleenomegaly TB TYPES AND PA12.2 Protrein energy and parasitology exercises in GIT Lymphnode 26/7/21 MON PATHOPHYSIOLOGY OF malnutrition & starvation (L) Slides TB Lymph node Hodgkins Lymphoma ( ANGINA (SGD) Pracs B) MI4.1.2 (Lecture (Batch A) Applied bacteriology, virology PH 1.28.3 - 1.28.10 - NITRATES & PH 3.1 PRESCRIPTION WRITING - Batch 27/7/21 TUE 12)Tetanus and parasitology exercises in GIT COM MED SDL CCBs (L) A

PA 19 Specimen - Splenomegaly TB Lymphnode CM 3 Common MI4.1.5 (Lecture 13) PH 3.1 PRESCRIPTION WRITING - Batch 28/7/21 WED Slides TB Lymph node Hodgkins Lymphoma ( SPORTS /ECA nutritional disorders Infections of Nonsporing B Pracs A) anaerobes PH 1.28.11 - 1.28.21 CARDIOPROTECTIVE DRUGS AND CM 1 Concept of causation, germ 29/7/21 THURS PA 12.3 Obesity (L) PERIPHERAL VASCULAR DISEASES theory SGD (L)

MI4.2 (Lecture 14) MI4.3.6 (SGD 4) PA 19.1 19.6 19.7 Bone & joint PA 24.1 Oral Cancers & Salivary Tissue nematode Lymphadenopathy 30/7/21 FRI Pandemic 2.4 infections gland tumors (L) infections of skin & Splenomegaly and soft-tissue (SGD)

IM22.10:Enumerate the causes of describle the clinical and laboratory features of metabolic alkalosis. IM22.11:Enumerate the causes and describe the clinical and laboratory features of respiratory acidosis. SU 5.4 - Discuss the medicolegal OG10.1.1 APH: 31/7/21 SAT AETCOM2.5 IM22.12:Enmerate the aspects of wound Placenta praevia causes and describe the clinical and laboratory features of respiratory alkalosis IM22.13:Identify the underllying acidebased disorder based on the ABGreport and clincial situation.

1/8/21 SUN MI4.3.1 (BATCH A) Gram stain PH 1.33 exercise Gram stain of Cl.tetaniDemo) PA 24.2 24.3 Peptic Ulcer Disease 2/8/21 MON PHARMACOTHERAPY OF PA 22 Blood Grouping & OSPE(Pracs B) COM MED SDL (L) Demonstration of sample collection, – COUGH (SGD) (collection of pus) AE 3- 1.Cellulitis (Streptococcus pyogenes), 2.Surgical site MI4.3 (Lecture MI4.3.1 (BATCH A) Gram stain PH 3.1 PRESCRIPTION WRITING - Batch 3/8/21 TUE PATHO SDL 15) PH 1.29 DRUGS USED CHF (L) exercise Gram stain of Cl.tetaniDemo) A Introduction to Demonstration of sample collection, – CM 9 Demography MI4.3.2 (Lecture 16) PH 3.1 PRESCRIPTION WRITING - Batch PH 1.30.1 - CARDIAC 4/8/21 WED PA 22 Blood Grouping & OSPE(Pracs A) intoduction Leprosy, (Atypical B ELECTROPHYSIOOGY CM 1. Prevention – Concept, PA24.6 Inflammatory PH 1.30 PHARMACOTHERAPY OF 5/8/21 THURS Levels of prevention, application CARDIAC ARRHYTHMIAS (L) Bowel Diseases (L) of interventions

MI4.3.3- (Lecture MI4.3.3a (lecture PA 19.2 Tuberculous 6/8/21 FRI 17) Herpes viruses PA 24.7 CA Colon (L) 18)Viral Pandemic 2.4 lymphadenitis (SGD) exanthematous

IM23.1:Discuss and describe the methods of nutritional assessment in an adult and calculation SU 4.1 - Elicit document and of caloric requirements present history in a case of Burns OG10.1.2 APH: 7/8/21 SAT during illnesses. and perform AETCOM 2.5 Abruptio Placenta IM23.2:Discuss and physical examination. Describe describe the causes and Pathophysiology of Burns. PH 1.34.1 - PHYSIOLOGY OF consequences of protein VOMITTING caloric malntrition in the PH 1.34.8 - PHYSIOLOGY OF hospitla. GASTRIC ACID SECRETION 8/8/21 SUN MI4.3.2 - (Batch A) ZN staining - Demonstration of slides of 1. M Leprae, PH 1.34.2 - 1.34.7 PA 25.2 25.3 Hepatic Failure & PA 23.1 Urine Analysis - Physical & Chemical ( Pracs 9/8/21 MON preparation of Slit Skin Smear demo ANTIEMETICS (SGD) Hepatitis (L) B) (video) PH 1.31.1-1.31.2 - LIPID METABOLISM MI4.3.4 (lecture 19) MI4.3.2 - (Batch B) ZN staining - PH 1.31.3 - 1.31.10 PH 3.1 PRESCRIPTION WRITING - Batch 10/8/21 TUE Superficial mycoses Demonstration of slides of 1. M Leprae, MICRO SDL HYPOLIPIDEMIC DRUGS (L) A preparation of Slit Skin Smear demo (video) CM 9 Fertility rates MI4.3.5 (Lecture 20) PA 23.1 Urine Analysis - Physical & Chemical ( Pracs PH 3.1 PRESCRIPTION WRITING - Batch 11/8/21 WED SPORTS /ECA and indices Subcutaneous mycoses A) B PA 25.4 & 25.5 CM 2 socio-cultural factors, Alcoholic Cirhosis & PH 1.34.8 - 1.34.14 DRUGS USED 12/8/21 THURS Types of family, its role in health IN PEPTIC ULCER (L) Portal Hypertension and disease SGD (L) MI5.1.1(Lecture 21) MI5.1.2a (SGD 5) PA 27.1 Arteriosclerosis & PA 20.1 Myeloma 13/8/21 FRI Introduction to Pyogenic meningitis Pandemic 2.4 atherosclerosis (L) Chart (SGD) CNS infections IM23.3:Discuss and describe the aetiology, causes, clinical manifestations, complcations, diagnosis SU4.2 - Describe Clinical features, OG14.2.1 and managementof Diagnose type and extent of burns 14/8/21 SAT Mechanism of AETCOM 2.5 common vitamin and deficiencies plan appropriate treatment. normal labour IM23.4:Enumerate the indications for enteral and parenteral nutrition in critically ill patients 15/8/21 SUN MI4.3.4,5 AE : (Batch A) PA 24.3 Specimen - Peptic Ulcer CA Stomach CA PH 1.34.15 - 1.34.18 Dermatophytoses & Mycetoma collection Colon & TB Instestine 16/8/21 MON DRUGS USED IN PA 27.5 Ishemic heart disease (L) Slides - Pleomorphic adenoma , carcinoma colon, TB CONSTIPATION (SGD) of sample KOH mount, culture,Slide culture;LPCB mount MI4.3.3 AE - Viral instestine CA Stomach ( Pracs B) MI5.1.2 (Lecture PH 1.32 DRUGS USED IN MI4.3.4,5 AE : (Batch B) PH 3.1 PRESCRIPTION WRITING - Batch 17/8/21 TUE BRONCHIAL ASTHMA AND COPD 22) Pyogenic Dermatophytoses & Mycetoma collection A SPORTS /ECA meningitis (L) of sample KOH mount, culture,Slide PA 24.3 Specimen - Peptic Ulcer CA Stomach CA CM 7.8 Association MI5.1.3 (SGD 6) Chronic PH 3.1 PRESCRIPTION WRITING - Batch 18/8/21 WED Colon & TB Instestine meningitis MI5.1.4 B and causation Slides - Pleomorphic adenoma , carcinoma colon, TB Aseptic meningitis - PA 26.1 26.2 PH 1.32 DRUGS USED IN 19/8/21 THURS Pneumonia & Lung BRONCHIAL ASTHMA AND COPD CM 5 Nutrition Practicals 1 abscess (L) (L) 20/8/21 FRI

Im25.1:Describe and discuss the response and the influence of host immune status, risk facators and comorbidites on zoonotic OG14.2.2 diseases(e.g.Leptspiro SU 4.3 - Discuss the Medicolegal Monitoring of 21/8/21 SAT sis, Rabies) and non- AETCOM 2.6 aspects in burn injuries labour (Partogram febrile infections & Dystocia) disease(e.g. Tetanus) IM25.2: Discuss and describe the common causes, pathophysiology and manifestations of these diseases.

22/8/21 SUN MI5.2.7,8 (Batch A) Spotter - PH 1.34.19 - 1.34.26 PA25 Specimen - Cirrhosis , Calculous PA 26.3 Chronic Bronchitis & Polio vaccine,hydatid cyst MI5.2.8 23/8/21 MON ANTIDIARRHOEAL cholecystis Slides - Cirrhosis & cholecystitis ( Emphysema (L) DRUGS, IBD, IBS (SGD) AE 1.Rabies - using Negri body Pracs B) PH 1.25.1 - COAGULATION slide/photograph MI5.2.122.- CASCADE MI5.1.5 (Lecture MI5.2.7,8 (Batch B) Spotter - 23) Fungal PH 1.25.2 - 1.25.18 COAGULANTS PH 3.2 CRITICAL APPRAISAL OF 24/8/21 TUE Polio vaccine,hydatid cyst MI5.2.8 meningitis & ANTICOAGULANTS (L) AE 1.Rabies - using Negri body PRESCRIPTION - Batch A slide/photograph MI5.2.122.- MI5.2.1 (Lecture 24) Viral CM 7.8 Biases in PA25 Specimen - Cirrhosis , Calculous encephalitis PH 3.2 CRITICAL APPRAISAL OF 25/8/21 WED cholecystis Slides - Cirrhosis & cholecystitis ( epidemiological PRESCRIPTION - Batch B SPORTS /ECA studies Pracs A)

PH 1.25.19 - 1.25.25 PA 26.4 Tuberculosis 26/8/21 THURS FIBRINOLYTICS & CM 5 Nutrition Practicals 2 (L) ANTIFIBRINOLYTICS (L) MI5.2.4 (SGD 7 ) PA 21.3 Platelet vs PA 26.5 Occupational Lung 27/8/21 FRI MI5.2.2 Lecture 25) Polio Slow viral Clotting disorders Pandemic 2.4 Disease (L) infections (SGD) IM25.3:Describe and discuss the pathophysiology and SU 4.4 - Communicate and OG19.1.1 Changes manifestations of counsel patients and families on during normal these diseases. the outcome 28/8/21 SAT puerperium & AETCOM 2.6 IM25.8:Enumerate the and rehabilitation advise (including indications for use of demonstrating empathy and contraception) newer techniques in care. the diagnosis of these PH 1.35.1 & 1.35.2 - TYPES OF infections. ANEMIA & IRON METABOLISM 29/8/21 SUN MI5.1.8,9,10 (Batch A) AE.Pyogenic PH 1.35.3 ORAL & meningitis- Sample collection - CSF PA 26.6 26.7 Tumors of Lung & 30/8/21 MON PARENTERAL IRON PREP. (Manequin) 1.Meningococcus, H.influenzae . PA 27 Specimen & Slides- Atherosclerosis & MI ( Pracs B) Pleura & Mesothelium (L) (SGD) 2. Neonatal meningitis - Streptococcus agalctiae MI5.1.13 AE- 3.Tubercular MI5.1.8,9,10 (Batch B) AE.Pyogenic MI5.2.5 (SGD 8) meningitis- Sample collection - CSF MI5.2.5 (Manequin) 1.Meningococcus, H.influenzae . Parasitic meningitis PH 1.52 PHARMACOTHERAPY OF 2. Neonatal meningitis - Streptococcus PH 3.2 CRITICAL APPRAISAL OF 31/8/21 TUE and encephalitis POISONING (L) agalctiae MI5.1.13 AE- 3.Tubercular PRESCRIPTION - Batch A Toxoplasmosis, meningitis MI5.1.16. AE 4.Cryptococcal cerebral malaria meningitis MI5.2.11 AE - cerebral abscess - Anaerobes/ Staphylococcus/ Nocardia/

MI5.2.3 (Lecture 26) CM 3.1 Air pollution PA 27 Specimen & Slides- Atherosclerosis & MI ( PH 3.2 CRITICAL APPRAISAL OF 1/9/21 WED Rabies SPORTS /ECA and Water pollution Pracs A) PRESCRIPTION - Batch B

PA23.2 Body Fluid & PH 1.56 GERIATRIC & PEDIATRIC 2/9/21 THURS CM 9 Demography Practicals Semen analysis (SGD) PHARMACOLOGY (L)

MI5.2.5 (SGD 9) MI6.1-6.4 (Lecture MI5.2.5 27) Introduction to Parasitic meningitis URTI -normal and encephalitis structure & protective PA 10.1 10.2 Malaria Cystercosis Primary amoebic PA 10.4 Infectious 3/9/21 FRI mechanisms, (SGD) encephalitis diseases (SGD) etiology, MI5.2.6 pathogenesis, general Infectious space lab occupying lesions of diagnosis, treatment. CNS IM14.1:Define and measure obesity as it relates to the indian population IM14.2:Describe SU12.1 - Enumerate the causes and anddiscuss the aetiology OG19.1.2 consequences of malnutrition in 4/9/21 SAT of obesiy including Abnormal AETCOM 2.6 the modifiable and non- surgical patient puerperium modifiable risk factors and secondary causes IM14.3:Describe and discuss the monogenic forms of obesity. 5/9/21 SUN MI6.1.3 &4 (Batch A ) AE otitis Proteus, PA 26 Specimen - Pneumonia, Broncheictasis, PH 1.53 CHELATING Aspergillus MI6.1.5 AE-white patch in oral 6/9/21 MON PA 24.4 CA Stomach (SGD) Emphysema, TB & Carcinoma Lung AGENTS (SGD) cavity - Albert stain, AE- CAP S.pneumo, Slides- Pneumonia & TB ( Pracs B) H.influenzae, K.pneumoniae VAP Acinetobacter MI 6.2 AE Gram's staining - MI6.1.3 &4 (Batch B) AE otitis Proteus, MI6.1.7&8 (SGD 10 Aspergillus MI6.1.5 AE-white patch in oral ) cavity - Albert stain, AE- CAP S.pneumo, Community acquired H.influenzae, K.pneumoniae VAP PH 3.2 CRITICAL APPRAISAL OF 7/9/21 TUE pneumonia - PH 1.49 ANTI CANCER DRUGS (L) SPORTS /ECA Acinetobacter MI 6.2 AE Gram's staining - PRESCRIPTION - Batch A Pneumococcus, with history - otitis media, sinusitis MI H.influenzae 6.3.1,2,3 AE Gram's staining - sputum (pneumococcus, Klebsiella, quality of (Lecture 28) MI6.1.5 Diphtheria PA 26 Specimen - Pneumonia, Broncheictasis, CM 3.5 Housing PH 3.2 CRITICAL APPRAISAL OF 8/9/21 WED Emphysema, TB & Carcinoma Lung PRESCRIPTION - Batch B standards Slides- Pneumonia & TB ( Pracs A)

PA 24 GIT Tutorial 9/9/21 THURS PH 1.49 ANTICANCER DRUGS (L) CM 7 Epidmiology Practicals 1 (SGD)

10/9/21 FRI

IM14.4:Describe and discuss the impact of environmental factors including eating havits, food, work, environment and physial activiy on the incidence of obesity. SU12.2 - Describe and discuss IM14.5:Describe and the methods of estimation and discuss the natural replacement of OG19.1.3 11/9/21 SAT AETCOM 2.7 history of obesity and the fluid and electrolyte Contraception its complications. requirements in the surgical IM14.8:Generate a patient differential diagnosis based on the presenting symptoms and clinical features and prioritise based on the most likely diagnosis.

12/9/21 SUN (Batch A) MI6.3.4 Acid fast staining (5) PH 1.58 DRUGS USED IN PA 25.1 Bilirubin metabolism & 13/9/21 MON OCCULAR DISORDERS Revision Practicals( B) Jaundice (SGD) (SGD) (SGD 11) (Batch B) MI6.3.4 Acid fast staining (5) MI6.1.6 Whooping cough PH 1.50 IMMUNO MODULATORS PH 3.2 CRITICAL APPRAISAL OF 14/9/21 TUE and (L) PRESCRIPTION - Batch A Group B.pertusis, Parainfluenza (Lecture 29) MI6.1.13 Viral CM 3.7 Vector PH 3.2 CRITICAL APPRAISAL OF 15/9/21 WED pneumonia - Influenza Revision Practicals( A) SPORTS /ECA Control PRESCRIPTION - Batch B viruses (Corona) PA 25 Formative 16/9/21 THURS assesment PH 1.54 VACCINES & ANTISERA (L) CM 7 Epidmiology Practicals 2 Hepatobiliary (SGD) MI6.1.15 (Lecture 30) Mycobacterium ( SGD 12) MI6.1.12 Pa27.4 27.6 tuberculosis- class PA 27.7 27.9 Pericarditis Viral lower Rheumatic fever & 17/9/21 FRI 1 Pericardial effusion & respiratory infective endocarditis cardiomyopathy (SGD) infections - Adeno, (SGD) RSV, EBV

PH 1.57 DRUGS USED IN SKIN DISEASE SU12.3 - Discuss the nutritional 18/9/21 SAT requirements of surgical 19/9/21 SUN PH 1.57 (batch A) MI 7.2.3 AE Discharge per vagina PA 27.2 27.3 27.10 Aneurysms (differnce between bacterial vaginosis& 20/9/21 MON PHARMACOTHERAPY OF Revision Practicals ( B) PH 1.51 - PESTICIDES & Heart Failure & Syphilis (SGD) bacterial vaginitis), Urethral syndrome MI SKIN DISORDERS (SGD) INSECTICIDES 7.2.2 (SGD 13) MI6.1.11 (batch B) MI 7.2.3 AE Discharge per vagina PH 1.51 OCCUPATIONAL & (differnce between bacterial vaginosis& Atypical Pneumonia - PH 1.62 ANTISEPTICS & DISINFECTANTS 21/9/21 TUE ENVIRONMENTAL Mycoplasma, bacterial vaginitis), Urethral syndrome MI - Batch A Chlamydia, viral PHARMACOLOGY (L) 7.2.2 AE-ulcerative lesions in the external genitalia PH 1.62 ANTISEPTICS & DISINFECTANTS 22/9/21 WED class test (lecture 31) MI6.1.16 Revision Practicals ( A) Mycobacterium tuberculosis- - Batch B PA 27 Formative 23/9/21 THURS REVISION (L) End Term test Assesment CVS (SGD)

(SGD 14)Tb- lab MI6.1.17(SGD 15) diagnosis with PA 26 Formative assesment PA 10.4 Infectious 24/9/21 FRI Atypical Myco bacteria diagnostic algorithm RS(SGD) diseases (SGD) and treatment - integrated with Path, Pharmac

IM14.10:Describe the indications and interpret the results of tests for secondary causes of obesity. IM14.13:Describe and enumerate the indications, pharmacology and side effects of SU12.3 - Discuss the nutritional OG22.1 & 22.2 requirements of surgical patients, pharmacotherapy for Physiological and 25/9/21 SAT the AETCOM 2.7 obesity. pathological vaginal methods of providing nutritional IM14.14:Describe and discharge enumerate the support and their complications indications and side effects of bariatric surgery. IM14.15:Describe and enumerate and educate patients, health care workers and the public on measures to prevent obesity and promote a healthy lifestyle. 26/9/21 SUN 27/9/21 MON Pathology Practical Revision ( SGD) 28/9/21 TUE 29/9/21 WED INTERNAL ASSESSMENT II- PATHO/ PHARMAC/ MICRO 30/9/21 THURS

PATHOLOGY MICROBIOLOGY PHARMACOLOGYCOM MED MEDICNE SURGERY OBG AETCOM

lecture 26 31 25 12 11 11 11 SGD/DOAP /PRACTICA LS 45 40 36 13 0 0 0 16

SDL 4 4 9 4 0 0 0 MVJ Medical College And Research Hospital Integrated and Aligned Time table Block -3 Teaching Program - Theory, Practicals Block -3 01 -10-2021 to 31-12-2021

8.30 - 1.30 - Time 11.30 - 12.30 12.30 - 1.30 2.00 - 4.00 4 TO 5 11.30 2.00 Date Day clinicals Lecture class Lecture class lunch Practicals /SGD/SDL SDL SPRTS /ECA Microbiology Pathology Pharmacology Community Medicine AETCOM MI6.1.18 & 19(lecture 1) Fungal infections of lower 01/10/21 FRI PH 1.67.1 - HPA axis (SGD) PA (SGD) MICRO SDL respiratory tract

02/10/21 SAT GANDHI JAYNATHI 03/10/21 SUN HOLIDAY MI 8.1.3,4,5 AE- PUO (A batch PA28.1 28.5 28.6 Histology praticals 50) PH 1.37.2 - Pharmacotherapy Kidney. Pathology of Brucellosis leptospirosis SEROLOGY PA - REVISION - Hematology 04/10/21 MON of Growth Hormone excess & PATHO SDL Glomerulonephritis & Ig A Brucella Agg (Pracs B) deficiency (L) nephropathy(L) Leptospirosis Weil Felix MI 8.1.3,4,5 AE- PUO (B batch MI6.1.21(sgd 1) praticals 50) Immunoprophylaxis of PH 1.37.3 - GnRH Brucellosis leptospirosis SEROLOGY 05/10/21 TUE PH- Practicals - Revision COM MED SDL Respiratory infection analogues (L) Brucella Agg Leptospirosis Weil Felix

06/10/21 WED MAHALAYA AMAVASYA PA 28.8 28.9 28.10 Tubular PH 1.37.4 - Androgens, PH CM 3.7 Medical Entomology 07/10/21 pathology and 1.37.5 - Testosterone THUR SGD pyelonephritis(L) (SGD) MI6.1.20 (SGD 2) PA 28. Urinary system General diagnosis of Specimen- Chronic pulmonary parasitic PH 1.37.7, PH 1.40 - pyelonephritis, Renal stones 08/10/21 FRI SPORTS /ECA infections- Lung flukes, Erectile dysfunction (SGD) with hydronephrosis, Renal cell Paragonimus carcinoma(SGD)

MI6.1.14(SGD 3) PA 28.2 28.3 28.4 Acute PH 1.37.6 - Anabolic steroids & Pneumonia in 09/10/21 SAT and chronic Renal failure, AETCOM 2.7 anti-androgens (SGD) immunocompromised RFT(SGD)

10/10/21 SUN SUNDAY PA28.7 28.11 28.15 Glomerular manifestations PA 28 Urinary system MI8.1.6 AE-Lab diagnosis of PH 1.37.8 - Estrogen & of systemic disease, 11/10/21 MON dengue, chikungunya (A batch MICRO SDL Progesteron(L) vascular diseases of kidney Slide- Chronic pyelonephritis, praticals 51) and thrombotic Renal cell carcinoma (Pracs B) angiopathies(L)

MI 7.1(LECTURE 2) Normal PH 1.37.10 - 1.37.11 - PH 3.3 - Drug Promotion anatomy & infections of MI8.1.6 AE-Lab diagnosis of SERMS, Antiestrogens, literature, PH 3.6 - 12/10/21 TUE Genito urinary system- dengue, chikungunya (B batch PATHO SDL Antiprogestins, Aromatase Interaction with Pharma pathogenesis, general lab praticals 51) inhibitors (L) representative (Batch A) diagnosis

MI 7.2.7(SGD 4) PA 28 Urinary system PH 3.3 - Drug Promotion CM 13.1& 13.2 Disaster Prevention measures in literature, PH 3.6 - 13/10/21 WED SPORTS /ECA Management STD Slide- Chronic pyelonephritis, Interaction with Pharma Renal cell carcinoma (Pracs A) representative (Batch B)

14/10/21 THUR AYUDA POOJA

15/10/21 FRI VIJAYADASHAMI MI 7.2.1& PH 1.37.9 - HRT PA 28.12 28.13 Cystic 2.2(LECTURE 3) 16/10/21 SAT PH 1.39- Hormonal diseases of kidney and Pathogens causing AETCOM 2.8 PH 1.36.7 - THYROID HORMONES contraceptives (SGD) obstructive uropathy(SGD) ulcerative Lesions in the genital tract 1- 17/10/21 SUN SUNDAY Mi8.1.8&9 (PRATICALS 52 A BATCH) PA 29 Male genital system Stool Examination (5)-larva of Specimen- Seminoma testis, PH 1.36.8 - 1.36.9 - Thyroid Strongyloides Demonstration of 18/10/21 MON PA28.14 Renal tumours(L) Carcinoma penis COM MED SDL and Antithyroid drugs(L) specimen Taenia adult Slide-Seminoma testis, Benign worms,hydatid cyst & slide of prostatic hyperplasia(Pracs B) hydatid cyst

Mi8.1.8&9 (PRATICALS 52 B BATCH) Stool Examination (5)-larva of MI 7.2.10(SGD 5) PH 1.38.1 - 1.38.2 - Strongyloides Demonstration of PH 2.2 - ORS (DOAP) 19/10/21 TUE Congenital infections MICRO SDL Corticosteroids (L) specimen Taenia adult (Batch-A) worms,hydatid cyst & slide of hydatid cyst

MI 7.2.2 (LECTURE 4)Pathogens causing PA 29 Male genital system ulcerative Lesions in the Specimen- Seminoma testis, CM 13.1& 13.2 Disaster PH 2.2 - ORS (DOAP) 20/10/21 WED genital tract 2 Carcinoma penis Management (Batch-B) ( Haemophilus ducreyi, Slide-Seminoma testis, Benign LGV Calymmatobacterium prostatic hyperplasia(Pracs A) granulomatis, Herpes PH 1.38.32 - 1.38.4 - PA 29.1 29.2 Testicular Inhalational and topical CM 7.3 Sources of 21/10/21 THUR tumours and carcinoma penis PATHO SDL corticosteroids epidemiological data (L) MI 7.2.3(LECTURE 5) (SGD) PA 30 Female genital system Pathogens causing urethral Specimen-Leiomyoma, discharge/ white discharge PH 1.37.12 - Treatment of Carcinoma cervix, Benign Cystic per vagina (Gonnorhoea, 22/10/21 FRI Infertility Teratoma, Serous/Mucinous SPORTS /ECA Candida, Trichomonas (SGD) Cystadenoma. Hydatidiform vaginalis, Bacterial mole .(SGD) vaginosis)

MI 7.3(LECTURE 6) Urinary tract PA 28 Formative PH 1.41 - Uterine stimulants & infections - E.coli, 23/10/21 SAT assesment urinary AETCOM 2.8 relaxants (SGD) Klebsiella, Proteus, system(SGD) Enterococcus, others

24/10/21 SUN SUNDAY PA 30 Female genital system PA 29.3 29.4 29.5Benign MI8.2 AE ( A BATCH PRATICALS 53) prostatic hyperplasia, 25/10/21 MON PH 1.36.1 - 1.36.2 - Insulin (L) Candidiasis Mucromycosis Slides- Leiomyoma, COM MED SDL carcinoma prostate and Serous/Mucinous prostatitis(L) Cystadenoma, Hydatidiform MI8.1&1.1(LECTURE 7) MI8.2 AE ( B BATCH PRATICALS 53) PH 4.2.1, 4.2.2 - CAL - Introduction to zoonotic PH 1.36.3 - 1.36.4 - Oral 26/10/21 TUE Candidiasis Mucromycosis Vasopressor agents (Batch MICRO SDL infections, Anthrax hypoglycemic drugs (L) A) PA 30 Female genital system

Slides- Leiomyoma, PH 4.2.1, 4.2.2 - CAL - 27/10/21 WED CM 15.1 & 15.2 Mental health MI8.1.2(SGD 6) Plague Serous/Mucinous Vasopressor agents (Batch Cystadenoma, Hydatidiform B) mole. Benign Cystic Teratoma.(Pracs A)

PH 1.36.5 - 1.36.6, PA 30.1 30.6 Carcinoma cervix CM 7.9 Application of 28/10/21 THUR Treatment of diabetic PATHO SDL and cervicitis(L) computers in epidemiology complications (SGD) PH 1.36.10 - 1.36.12 - MI8.1.3(LECTURE 8) Calcium & Phosphorus 29/10/21 FRI Brucellosis PA- Instruments (SGD) Homeostasis & VIT D (SGD) PH 1.36.13 - 1.36.15 - MI8.1.6(SGD 7) Viral PA 29 Formative Bisphosphonates, hemorrhagic fevers 30/10/21 SAT assesment male genital AETCOM 2.8 Management of Calcium - Yellow fever,Ebola, system(SGD) imbalance (SGD) Roboviruses (Hanta, 31/10/21 SUN SUNDAY

01/11/21 MON KANNADA RAJYOTSAVA

MI8.7 (B BATCH PRATICALS 54) MI8.1.4(LECTURE 9) PH 1.42.1- 1.42.3 - General Donning & doffing of PPE for a 02/11/21 Leptospirosis , Borreliosis principles of Practical Revision (Batch A) SPORTS /ECA TUE given situation - 1 Chemotherapy (L)

03/11/21 WED NARAKA CHATURDASHI PA 30.2 30.7 30.8 30.9 PH 1.42. 4- 1.42.5 - Carcinoma endometrium, CM 7.9 Application of 04/11/21 THUR Antimicrobial endometriosis, adenomyosis computers in epidemiology combinations (SGD) and endometrial hyperplasia(L) 05/11/21 FRI BALIPADAYAMI MI8.1.8(SGD 8) PA 32.2 32.3 Taeniasis, PH 1.43.1 - 1.43.3 - Rational Thyrotoxicosis, 06/11/21 SAT (Cysticercosis, partly AETCOM 2.8 PATHO SDL antimicrobial use (SGD) hypothyroidism and covered in CNS) and TFT(SGD) (Hymenolepiasis) 07/11/21 SUN SUNDAY PA 31 Breast MI8.7 (A BATCH PRATICALS 54) Specimen- Fibroadenoma. PH 1.42.9 - Quinolones & PA 30.4 Ovarian Donning & doffing of PPE for a Carcinoma breast (Optional) 08/11/21 MON MICRO SDL Fluoroquinolones (L) tumours(L) given situation - 1 Slide- Fibroadenoma. Carcinoma breast (Optional)(Pracs B)

MI8.1.5(LECTURE 10) MI8.7 (B BATCH PRATICALS 55) Rickettsial infections, Other PH 4.2.3 - CAL - PH 1.42.10 - 1.42.11 - Donning & doffing of PPE for a 09/11/21 TUE zoonoses (Nontyphoidal Vasodepressor agents Penicillins (L) given situation - 2 Salmonellosis, Prions, Zoonotic (Batch A) mycoses) MI8.2(SGD 9) Introduction PA 31 Breast to opportunistic infections Specimen- Fibroadenoma. & viral opportunistic PH 4.2.3 - CAL - Carcinoma breast (Optional) 10/11/21 CM 19.2 Essential drugs infections, candidiasis Vasodepressor agents WED Slide- Fibroadenoma. (Also (Batch B) Carcinoma breast covered in HIV-CVS MI2.7) (Optional)(Pracs A) PA 30.5 Gestational PH 1.42.13 - Other Beta 11/11/21 THUR CM 19.1 NLEM trophoblastic neoplasms(L) lactam antibiotics (SGD)

MI8.1.6(LECTURE 11) Arboviral infections- Classification, PH 1.45.5 - 1.45.6 - 12/11/21 FRI Spotted fever group, Dengue, Antibiotic Stewardship PA- instruments (SGD) COM MED SDL Chukungunya, KFD, Gen Lab programme(SGD) diagnosis; (Zikavirus) MI8.2(SGD 10) Opportunistic Intestinal parasitic infections - Cystisosporiasis, PH 1.42.6 - 1.42.8 - PA 30 Formative Cryptosporidiasis, 13/11/21 SAT Sulphonamides & assesment female genital AETCOM 2.8 SPORTS /ECA Cyclosporiasis, Cotrimoxazole (SGD) system(SGD) Microsporidiasis and Strongyloidiasis, Giardia - (covered in GIT 3.3)

14/11/21 SUN SUNDAY PA 32 Endocrine System Specimen- Multinodular goitre, MI8.7 (A BATCH PRATICALS 55) PA 31.1 31.4 Benign Papillary carcinoma PH 1.42.12 - Cephalosporins Donning & doffing of PPE for a 15/11/21 MON diseases of breast and Slide- Multinodular goitre, (L) given situation - 2 gynecomastia(L) Hashimoto’s thyroiditis, Papillary carcinoma thyroid(Pracs B) MI8.7 ( B BATCH PRATICAL 56) Donning & doffing of PPE for a PH 4.2.4, 4.2.5 - CAL - PH 1.42.19 - 1.42.20 - 16/11/21 TUE CLASS TEST given Graph analysis & Macrolides (L) situation - 3 interpretation (Batch A)

PA 32 Endocrine System Specimen- Multinodular goitre, Papillary carcinoma PH 4.2.4, 4.2.5 - CAL - MI8.1.9(LECTURE 12) 17/11/21 WED CM 18.1 international health Slide- Multinodular goitre, Graph analysis & Hydatid cyst disease Hashimoto’s thyroiditis, interpretation (Batch B) Papillary carcinoma thyroid(Pracs A)

PH 1.42.21 - 1.42.23 - CM 3.4 Principles behind Vancomycin, Linezolide, functioning of sanitary 18/11/21 THUR PA31.2 Carcinoma breast(L) Clindamycin & Misc latrines, human excreta antibiotics (SGD) disposal SGD

MI8.4(SGD 11) Emerging PH 1.42.19 - Broad 19/11/21 FRI PA- Charts (SGD) infections and bioterrorism spectrum antibiotics (SGD)

20/11/21 SAT 21/11/21 SUN SUNDAY PA 33 Bone tumors MI8.7 ( A BATCH PRATICAL 56) Specimen- Osteoclastoma, Donning & doffing of PPE for a PH 1.42.14 - 1.42.18 - Osteosarcoma 22/11/21 MON PA 33.1 Osteomyelitis(L) given Aminoglycosides (L) Slide- Osteoclastoma. situation - 3 Osteosarcoma (Optional)(Pracs B) MI8.6 (B BATCH PRATICLAS 57) 1.How to manage bio- spill in a simulated setting (AETCOM) PH 4.1.4 - 4.1.21 - Routes MI8.2(LECTURE 13) PH 1.44.1 - 1.44.4 - 2. Advice a HCW with needle stick 23/11/21 TUE in Manikins (DOAP) (Batch SPORTS /ECA Zygomycosis Antitubercular drugs (L) injury in complete and correct A) sequence in a simulated setting AETCOM 3. Segregate biomedical waste as PA 33 Bone tumors Specimen- Osteoclastoma, MI8.5(SGD 12) Hospital PH 4.1.4 - 4.1.21 - Routes CM 18.2 International health Osteosarcoma 24/11/21 WED Associated Infections in Manikins (DOAP) (Batch agencies Slide- Osteoclastoma. (seminar) B) Osteosarcoma (Optional)(Pracs A) CM 7.6 Evaluation & PH 1.44.5 - ATT 25/11/21 THUR PA 33.2 Bone tumours(L) Indicators for a screening test combinations (SGD) SGD PH 1.44.6 & PH 1.55.2 - NTEP, PH 26/11/21 FRI CLASS TEST PA- Charts (SGD) 1.45 - MDR & XDR TB, (SGD)

PH 1.47.1 - Stages of Malarial PA 33.3 Soft tissue 27/11/21 SAT SGD - REVISION AETCOM 2.8 parasites in Humans (SGD) tumours(SGD)

28/11/21 SUN SUNDAY #NAME? MI8.6 (A BATCH PRATICLAS 57) 1.How to manage bio- spill in a PA 35 Central nervous system PH 1.47.2 - 1.47.4 - PA 32.1 BenignThyroid simulated setting (AETCOM) Charts- Interpretation of CSF 29/11/21 MON Antimalarial drugs PH 1.55.4 - SPORTS /ECA disorders(L) 2. Advice a HCW with needle stick findings in various NVBDCP (L) injury in complete and correct meningitis(Pracs B) sequence in a simulated setting MI8.9 (B BATCH PRATICALS 58) MI8.3 (LECTURE 14)Oncogenic Collection of throat swab, PH 2.3 - IV drip, PH 30/11/21 TUE viruses -HPV, HTLV (HBV, PH 1.55.4 - NVBDCP (L) nasopharyngeal swab peripheral 4.1.22 - 4.1.31 - IM & IV HDV,,EBV etc) venous blood for culture in (DOAP) (Batch A) simulated

PA 35 Central nervous system PH 2.3 - IV drip, PH CM 7.5 epidemiological study MI8.6 (SGD 13)Biomedical Charts- Interpretation of CSF 01/12/21 WED 4.1.22 - 4.1.31 - IM & IV design waste management findings in various (DOAP) (Batch B) meningitis(Pracs A)

PH 1.46.1 - 1.46.3 - 02/12/21 THUR PA 32.4 Diabetes mellitus(L) Antileprotic drugs CM 7.5 study designs SGD SPORTS /ECA PH 1.55.3 - NLEP (SGD)

PH 1.55.4, 1.47.5 - 1.47.13 MI8.6(LECTURE 15) Antibiotic 03/12/21 FRI - Kala-azar & NVBDCP PA- (Gross specimens) SGD) stewardship (SGD)

PH 1.55.5 - 1.55.10 - National PA 32 .1 Thyroid 04/12/21 SAT SGD - REVISION AETCOM 2.8 Programmes (SGD) neoplasms(L)

05/12/21 SUN SUNDAY MI8.9 (A BATCH PRATICALS 58) Collection of throat swab, nasopharyngeal swab peripheral PH 1.47.14 - 1.47.22 - Revision slides/ specimen/ 06/12/21 MON PA 35.2 CNS tumours(L) venous blood for culture in Amoebiasis (L) charts(Pracs B) simulated situation MI8.6(LECTURE 16) Infection MI8.9 (B BATCH PRATICALS 59) control in hospitals- Principles, collection of wound swab and pus PH 4.1.32 - 4.1.42 - Routes components and application; PH 1.47.23 - 1.47.26 - sample in simulated situation 07/12/21 TUE in Manikins (DOAP) (Batch surveillance - standard & Anthelmintic drugs (L) A) transmission based Instruct sample collection precautions, HICC procedure (sputum, urine, stool,for PH 4.1.32 - 4.1.42 - Routes CM 7.5 epidemiological study MI8.8(SGD 14) Food, Revision slides/ specimen/ 08/12/21 WED in Manikins (DOAP) (Batch design water and air microbiology charts(Pracs A) B) PA 34.1 34.2 34.3 SCC, BCC PH 1.48.1 - 1.48.9 - UTI 09/12/21 THUR Term end test A BATCH and melanoma(L) (SGD) PH 1.48.10 - 1.48.17 - 10/12/21 FRI CLASS TEST PA-Gross specimens (SGD) STDs (SGD) MI8.9,10&11 (SGD 15) PA 34 33 19 35 Formative PH 1.48.18 -1.48.19 - Sample collection and 11/12/21 SAT assesment- Skin, bone, AETCOM 2.8 Antifungal drugs (SGD) transportation - (T/L CNS and lymph node(SGD) opportunities - General 12/12/21 SUN SUNDAY MI8.9 (A BATCH PRATICALS 59) collection of wound swab and pus PH 1.48.20 -1.48.21 - AE & DI PA 32 Formative sample in simulated situation Revision slides/ specimen/ 13/12/21 MON of Antifungal drugs (L) assesment endocrine(SGD) charts(Pracs B) Instruct sample collection procedure (sputum, urine, stool,for MI8.9 (B BATCH PRATICALS 60) skin scraping, hair clippings and nail MI8.16(LECTURE 17) National samples) collection procedure PH 4.1.43 - 4.1.60 - Local/ PH 1.48.22 - 1.48.23 - 14/12/21 TUE health programs on infectious independently in a simulated Topical Routes in Manikins Antiviral drugs (L) diseases - Integrated with PSM setting (covered in skin) (DOAP) (Batch A) Demonstrating respect to patient samples -OSPE MI8.14 (SGD 17) PH 4.1.43 - 4.1.60 - Local/ CM 7.5 epidemiological study Interaction with Revision slides/ specimen/ 15/12/21 WED Topical Routes in Manikins design ICTC staff - AETCOM charts(Pracs A) (DOAP) (Batch B)

PH 1.48.24 - Anti-influenza 16/12/21 THUR Revision (SGD) drugs (SGD) MI8.12(SGD 16) Discuss with help of case PH 1.60 - 17/12/21 FRI scenarios or role plays or Pharmacogenomics & PA-Gross specimens (SGD) AETCOM 2.8 videos Pharmacoeconomics (SGD) : a. Request form or container 18/12/21 SAT 19/12/21 SUN SUNDAY MI8.9 (A BATCH PRATICALS 60) skin scraping, hair clippings and nail samples) collection procedure PH 1.48.25 - 1.48.26 - 20/12/21 MON PA- Revision(SGD) independently in a simulated PA- slides( Pracs (B) Antiretroviral drugs (L) setting (covered in skin) Demonstrating respect to patient samples -OSPE PH 2.5 - Pandemic module PH 2.5 - Pandemic module 21/12/21 TUE CLASS TEST B -BATCH PRACTICALS REVISION (L) (SGD) - MI8.15(SGD 18) Case based discussion - reflection confidentiality- PH 2.5 - Pandemic module 22/12/21 WED COM MED - Internals PA-Revision slides(Pracs A) Pt identity, lab results) (SGD) - AETCOM

PH 2.5 - Pandemic module 23/12/21 THUR PA- Revision (SGD) TERM END TEST - BATCH B (L) 24/12/21 FRI PATHO/MICRO/PHARM III THEORY & PRACT Internals Pathology Practical revision ( SGD) 25/12/21 SAT CHRISTMAS DAY 26/12/21 SUN SUNDAY 27/12/21 MON

28/12/21 TUE 29/12/21 WED PATHO/PHARM/MICRO III THEORY & PRACT Internals 30/12/21 THUR 31/12/21 FRI

COM PATHOLOGY MICROBIOLOGY PHARMACOLOGY AETCOM MED

lecture 19 17 23 10 9 SGD/DOA P/PRACTI 55 29 53 20 CALS SDL 5 5 2 4 MVJ Medical College And Research Hospital Integrated and Aligned Time table Block -1 Teaching Program - Theory, Practicals Block -1 15 -03-2021 to 30-06-2021 8:30- 1.30- Date Day 10.00-11.00 11:30-12:30 12:30-1:30 2:00-4:00 2 TO 3 3 to 4 4 to 5 11.30 2.30 Practicals / Tutorial / Seminars / SGD/ DOAP Lecture SDL /SPORTS clinicals lecture lecture/SGD lunch / ECA Pathology Pharmacology Microbiology For Med Com Med OBG AETCOM

PA 2.5 Degeneration (BATCH A PRATicals )(sgd 1)Microscopy PH 1.1 - Principles of PA 1.1 Role of Pathologist in Specimens-Fatty liver - Types of microscopes, principles and MON SPORTS/ECA 15.3.21 Pharmacology (L) disease(SGD) Slides- Fatty liver, dystrophic applications of each Simple stain calcification, hyaline exercise and hanging frop (BATCH B PRATicals )Microscopy - FM1.1-1.2 - PH 2.1.1- Introduction to Types of microscopes, principles and Introduction, history PH 1.4.1-1.4.6 - Drug TUE Dosage forms (Batch A) applications of each Simple stain SPORTS/ECA 16.3.21 and defnition of Absorption (L) (DOAP) exercise and hanging frop Forensic Medicine (L) demonstration PA 2.5 Degeneration CM 7.1 Introduction MI1.1.1 ( LECTURE Specimens-Fatty liver PH 2.1.1- Introduction to 17.3.21 WED and uses of 1)Introduction to infectious Slides- Fatty liver, dystrophic Dosage forms (Batch B) MICRO -SDL epidemiology diseases and History calcification, hyaline (DOAP) degeneration(Pracs A) PA 1.2, 1.3 Introduction FM2.8- 2.10 - PH 1.3 - Drug formulations to Pathology with Postmortem changes THUR & Drug delivery systems CM 3.2 water quality SGD batch A PATHO -SDL 18.3.21 Historical and Time since death (SGD) aspects(Lecture) SGD Batch B FM2.8- 2.10 - MI1.1.2 (LECTURE PA 2.1 Cell Injury - Causes, Postmortem changes FRI 2)Morphology effects & Clinical CM 3.2 water quality SGD batch B 19.3.21 and Time since death FM-SDL &Physiology of Bacteria significance (Lecture) SGD Batch A 20.3.21 SAT 21.3.21 SUN PA 2.2 Etiology , PA 2.8Necrosis MI1.1.2.3 (BATCH A)Culture media and PH 1.4.7-1.4.11 - Drug morphology, reversible & Specimen- Gangrene methods (including anaerobic) pandemic module MON 22.3.21 Distribution (L) irreversible cell Slides- Coagulative necrosis, Caseous Identification of bacteria based on 2.1 injury(Lecture) necrosis(Pracs B) Biochemical tests MI1.1.2.3 (BATCH B)Culture media and FM 2.1-2.3,2.5,2.6,2.7 - PH 1.4.12 - 1.4.16 - PH 2.1.2 - Solid Dosage methods (including anaerobic) TUE 23.3.21 Death and its causes (L) Biotransformation (L) forms (Batch A) (DOAP) Identification of bacteria based on FM-SDL Biochemical tests PA 2.8 Necrosis MI1.3 (sgd 2)Epidemiology CM 7.2 Definitions in Specimen- Gangrene PH 2.1.2 - Solid Dosage WED & pathogenesis of SPORTS/ECA 24.3.21 epidemilogy (lecture) Slides- Coagulative necrosis, Caseous forms (Batch B) (DOAP) Infectious diseases necrosis(Pracs A)

FM 2.9 - Putrefaction, PA 2.3 Intracellular PH 1.5.1 - Mechanism of THUR mummification and CM 3.6 Entomology practicals A SPORTS/ECA 25.3.21 accumulations(Lecture) Drug action (SGD) adipocere SGD Batch B

MI1.1.3 (LECTURE FM 2.9 - Putrefaction, Pa 2.6 Cellular adaptation pandemic module FRI 3)Introduction to mummification and CM 3.6 Entomology practicals B 26.3.21 (SGD) 2.1 virology adipocere SGD Batch A IM4.1:- Describe and MI1.1.2.3 Culture discuss the febrile Media MI1.1.2.4 response, risk factors Principles of lab and comarbidities on diagnosis of SU1.1 - Describe Basic the febrile response infectious diseases concepts of homeostasis, OG2.1.1 Anatomy of IM4.2:- Describe and SAT – identification of enumerate the metabolic the female 27.3.21 discuss the febrile aetcom 2.2 bacteria changes in injury and their reproductive tract response Including (including mediators elderly HIV and Traavel biochemical tests) IM4.3:- Discuss and (SGD 1) describe the pathopysiology of 28.3.21 SUN MI1.1.3(BATCH A) Demonstration of PA 4.4 Acute Inflammation Viral Diagnostic methods -microscopy Specimen- Acute appendicitis, Lobar /culture/immunologi cal/molecular PH 1.4.17 - 1.4.22 - Drug PA 2.4 Cell death - Necrosis MI1.1.4 pandemic module 29.3.21 MON Pneumonia Excretion (L) & autolysis(Lecture) Slides- Acute appendicitis, Lobar Demonstration of Diagnostic methods 2.1 Pneumonia (Pracs B) used in Fungal infections - microscopy/culture/ Immunological/molecular MI1.1.5 MI1.1.3(BATCH B) Demonstration of Viral Diagnostic methods -microscopy /culture/immunologi cal/molecular MI1.1.4 FM 8.5,8.9,2.11,2.14- PH 1.4.23 - 1.4.24 - Drug PH 2.1.3 - Liquid Dosage Demonstration of Diagnostic methods TUE SPORTS/ECA 30.3.21 Medicolegal Autopsy (L) Excretion (L) forms (Batch A) (DOAP) used in Fungal infections - microscopy/culture/ Immunological/molecular MI1.1.5 Demonstration of Diagnostic methodsused in parasiticinfections - PA 4.4 Acute Inflammation Specimen- Acute appendicitis, Lobar CM 7.2 Modes of MI1.1.4 (LECTURE 4) PH 2.1.3 - Liquid Dosage 31.3.21 WED Pneumonia FM-SDL transmission (lecture) Introduction to mycology Slides- Acute appendicitis, Lobar forms (Batch B) (DOAP) Pneumonia(Pracs A)

FM 14.9,2.16- PA 2.7 Cellular aging & Examination of Mutilated THUR PH 1.2 - EBM, TDM (SGD) CM 3.6 Entomology practicals A SPORTS/ECA 1.4.21 Apoptosis (Lecture) bodies and skeletal remains Pract B

pandemic module FRI 2.4.21 2.2 IM4.5:- Describe and discuss the pathophysilogy of malignant causes of OG2.1.2 fever IM4.6:-Discuss MI1.1.5 (LECTURE SU 1.2 -Describe the factors Development of the and describe the SAT 5) Introduction to that affect the metabolic female reproductive MICRO -SDL 3.4.21 pathophysilogy and aetcom 2.1 parasitology response to injury. tract and its applied manifestaton of malaria anatomy IM4.7:- Discuss and describe the pathophysilogy and manifestaton of sepsis 4.4.21 SUN PA 4.4 Chronic Inflammation PA 4.1 Acute & Chronic Specimens- TB lymph node, Madura PH 1.5.2 - 1.5.5 - Inflammation - General foot pandemic module MON Receptor Mechanism MI1.2 (BATCH A)Gram staining (1) 5.4.21 Features, Etiology & Slide- Granulation tissue, TB lymph 2.2 (L) vascular events(Lecture) node, Actinomycosis, Rhinosporidiosis(Pracs B)

PH 1.5.6 - 1.5.8 - Factors PH 2.1.4 - Topical Dosage TUE FM3.1- Identification (L) MI1.2 (BATCH B)Gram staining (1) SPORTS/ECA 6.4.21 modifying drug action (L) forms (Batch A) (DOAP)

PA 4.4 Chronic Inflammation MI1.4.1 (LECTURE 6) Specimens- TB lymph node, Madura CM 7.2 cold chain and PH 2.1.4 - Topical Dosage WED Sterilization & Disinfection - foot 7.4.21 AEFI (lecture) forms (Batch B) (DOAP) FM-SDL Physical methods Slide- Granulation tissue, TB lymph node, Actinomycosis,

PA 4.1 Cellular Events PH 1.6 - Pharmacovigilance FM 2.18, -Crime scene CM 5.2 nutritiona assesment SGD THUR PATHO -SDL 8.4.21 (Lecture) & ADR reporting (SGD) investigation SGD B batch A

MI1.5.1 (SGD 4)Sterilization & FM 2.18, -Crime scene pandemic module FRI Disinfection, PA 3 Amyloidosis (SGD) CM 3.6 Entomology practicals B 9.4.21 investigation SGD A 2.2 Spaulding's classification, chemical IM4.16:- Enumerate the Indications and discribe the finding in fever of MI1.6.1 (LECTURE implamatry origin SU 1.3 - Describe basic 7) Bacterial IM4.18:- Enumerate by OG3.1.1 Physiology SAT concepts of perioperative MICRO -SDL 10.4.21 genetics indications for uses of of menstrual cycle aetcom2.1. care. (Bacteriophage) imaging in diagonosis of febrile syndromes IM4.22:- Describe and discuss antimaralaial 11.4.21 SUN PH 1.5.9 - 1.5.10 - Factors modifying drug PA 4.2 Mediators of Acute pandemic module MON SDL MI1.2(BATCH A) Gram staining (2) 12.4.21 action & Therapeutic Inflammation(Lecture) 2.2 index (L) 13.4.21 TUE 14.4.21 WED

FM2.32,2.33,2.35 - Mass PA 4.3(Lecture) Chronic PH 3.4.1, 3.4.3, 3.4.6, 3.4.7 - Disaster, communication Inflammation - ADR reporting CM 5.4 Nutrition problems batch THUR and collection of 15.4.21 Definition, causes, PH 1.7 - Management of A FM-SDL biological or trace types with examples ADR (SGD) evidences SGD B FM2.32,2.33,2.35 - Mass OG3.1.2 Physiology Disaster, communication MI1.7.1 (LECTURE PA 2 Formative Assesment CM 5.2 nutritiona assesment SGD of gametogenesis, pandemic module FRI and collection of 16.4.21 8)Immunity Cell Injury - (SGD) batch B fertilization, and 2.2 biological or trace implantation evidences SGD A

17.4.21 SAT 18.4.21 SUN PA 6.2, 6.7 CVC and Infarction PH 1.13.1 - 1.13.4 - Specimen- CVC Liver (Optional). Introduction to ANS & PA 5.1 Repair Regeneration Infarction- Spleen pandemic module MON MI1.2 (BATCH A) Acid fast staining (1) 19.4.21 Adrenergic receptors & Wound Healing (Lecture) Slide- CVC lung, CVC liver (Optional), 2.2 (L) CVC Spleen (Optional), Infarction- Spleen(Pracs B)

PH 1.13.5 - 1.13.11 - PH 2.1.5 - Other Dosage MI1.2 (BATCH B) Acid fast staining (1) TUE FM 3.2 Identification (L) SPORTS/ECA 20.4.21 Adrenergic drugs (L) forms (Batch A) (DOAP) MI1.2(BATCH A) Gram staining (2)

PA 6.2, 6.7 CVC and Infarction Specimen- CVC Liver (Optional). CM 7.3 Sources of MI1.7.4 (LECTURE Infarction- Spleen PH 2.1.5 - Other Dosage health information MICRO -SDL 9)Complement system Slide- CVC lung, CVC liver (Optional), forms (Batch B) (DOAP) (lecture) CVC Spleen (Optional), Infarction- 21.4.21 WED Spleen(Pracs A) FM 14.6-14.8- PH 1.8 - Drug Interactions Examination of Blood, CM 5.4 Nutrition problems batch PA 6.1 Edema (Lecture) COM MED -SDL (SGD) Hair,semen and other A 22.4.21 THUR biological fluids Pract B

FM 14.6-14.8- MI1.7.5 (LECTURE 10) PA 4 Formative Assesment - Examination of Blood, CM 5.4 Nutrition problems batch pandemic module Antigen-Antibody Inflammation (SGD) Hair,semen and other B 2.2 reactions biological fluids Pract A 23.4.21 FRI IM6.1:-Describe and discuss the symptoms and signs of acute HIV MI1.6.2 (SGD 5) seroconversion SU 2.1 - Describe OG4.1.1 Basic Principles and IM6.2:- Define and Pathophysiology of shock, embryology of fetus, types of antibiotic classify HIV AIDS based types of shock & principles and factors SAT susceptibility on the CDC criteria SPORTS/ECA 24.4.21 of resuscitation including influencing fetal testing (Introduce IM6.3:- Describe and fluid replacement and growth and MRSA, ESBL,MBL, discuss the resationship monitoring. development VRE) between CDC count and the risk of opportunistic infections. 25.4.21 SUN

PA 7 Benign tumors PH 1.13.12 - 1.13.14 - Specimen - Lipoma pandemic module PA 6.3 Shock (Lecture) MI1.2 (BATCH A )Acid fast staining (2) Alpha blockers (L) Slide- Hemangioma, Schwannoma, 2.2 Lipoma (Pracs B) 26.4.21 MON

PH 3.4.2, 3.4.4, 3.4.5, 3.4.8 - FM PH 1.13.15 - 1.13.17 - Beta Management of ADR & 8.2,8.3,8.4,8.6,8.8,8.10 - MI1.2 (BATCH B)Acid fast staining (2) SPORTS/ECA blockers (L) Causality assessment (Batch General Toxicology (L) A) 27.4.21 TUE PA 7Benign tumors PH 3.4.2, 3.4.4, 3.4.5, 3.4.8 - CM 7.4 Morbidity & MI1.8.1 (LECTURE Specimen - Lipoma Management of ADR & Mortality indicators 11)Immune response - SPORTS/ECA Slide- Hemangioma, Schwannoma, Causality assessment (lecture) Humoral 28.4.21 WED Lipoma (Pracs A) (Batch B) PA 6.4 Normal PH 1.13.20 - Glaucoma CM 11.4 occupational heath Hemostasis & FM 9.1- Corrosives SGD B SPORTS/ECA 29.4.21 THUR (SGD) spotters Batch A Thrombosis (Lecture) MI1.8.2(LECTURE 12) PA 5 Formative Assesment - FM 9.1- Corrosives SGD CM 5.4 Nutrition problems batch pandemic module Immune response - cell Healing & Repair(SGD) A B 2.2 30.4.21 FRI mediated 1.5.21 SAT 2.5.21 SUN PA 7Malignant tumors PH 1.13.18, 1.13.19, Specimen- Squamous cell carcinoma, 1.13.21 - Cardio- Adenocarcinoma pandemic module PA 6.5 Embolism (Lecture) MI1.2 (BATCH A)Stool examination (2) selective Beta blockers Slide- Squamous cell carcinoma, Basal 2.3 (L) cell carcinoma, Adenocarcinoma (Pracs 3.5.21 MON B) PH 1.14.1 - 1.14.7 - FM 9.3- Metallic PH 2.4.1, 2.4.3- Dose Cholinergic Receptors & MI1.2 (BATCH B)Stool examination (2) SPORTS/ECA Poisons (L) calculations (Batch A) 4.5.21 TUE Classification (L) PA 7 Malignant tumors Specimen- Squamous cell carcinoma, CM 7.6 Screening for MI1.10.1(LECTURE 13) Adenocarcinoma PH 2.4.1, 2.4.3- Dose COM MED -SDL diseases (lecture) Hypersensitivity -1 Slide- Squamous cell carcinoma, Basal calculations (Batch B) cell carcinoma, Adenocarcinoma (Pracs 5.5.21 WED A) PA 7.1 Neoplasia - PH 1.14.8 - 1.14.9 - FM 9.5- OP Poisoning CM 7.4 demography problems Definition classification SPORTS/ECA Anticholinesterases (SGD) SGD B Batch A 6.5.21 THUR &

PA 7.1 Neoplasia - MI1.10.2(LECTURE 14) FM 9.5- OP Poisoning CM 11.4 occupational heath pandemic module Definition classification & Hypersensitivity - 2 SGD A spotters Batch B 2.3 characteristics(Lecture) 7.5.21 FRI IM.6.4:- Describe and discuss the pathogenesis, evolution and clinical features of MI1.9 (SGD 6) common HIV related Immunological opportunistic infections OG4.1.2 Anatomy SU2.2 - Describe the clinical basis of vaccine & IM6.5:- Describe and and physiology of features of shock and its Universal discuss the placenta, and aetcom 2.1 appropriate treatment. Immunization pathogensis, evolution teratogenesis Schedule and clinical features of common HIV relaed skin and oral lesions IM6.6:- Describe and 8.5.21 SAT discuss the 9.5.21 SUN

MI1.5 (BATCH A)Physical methods of PA 7.4 7.5 sterilization - Demo MI1.5 Identify the PA 6 Formative PH 1.14.10 - 1.14.14 - Paraneoplastic most appropriate method of PA 7.2 Molecular basis of Assesment - pandemic module Myasthenia gravis & OP Syndrome & sterilization /disinfection in the cancer (Lecture) Hemodynamic 2.3 Poisoning (L) Immune response given case scenarios. Discuss the Disorders(SGD) to cancer(SGD) reason for choosing the method of sterilization /disinfection.

10.5.21 MON

MI1.5 (BATCH B)Physical methods of sterilization - Demo MI1.5 Identify the PH 2.4.2, 2.4.4, 2.4.5 - Dose most appropriate method of FM 9.4- Alcohol PH 1.14.15 - 1.14.22 - calculation in special sterilization /disinfection in the SPORTS/ECA Poisoning (L) Anticholinergic drugs (L) population (Batch A) given case scenarios. Discuss the reason for choosing the method of sterilization /disinfection. 11.5.21 TUE

PA 7.4 Ph 1.16.1 & 1.16.6 PA 6 Formative 7.5Paraneoplastic PH 2.4.2, 2.4.4, 2.4.5 - Dose Histamine, 5-HT , CM 11.1 introduction to MI1.10.3 (LECTURE 15) Assesment - Syndrome & calculation in special bradykinin, occupational healh Autoimmunity Hemodynamic Immune response population (Batch B) PROSTAGLANDIN Disorders(SGD) to cancer(SGD) ANALOGUES 12.5.21 WED PH 1.16.2 - 1.16.5 - PA 7.2 Molecular basis FM 9.6- Asphyxiants SGD CM 7.4 demography problems Histamine & anti-histamines SPORTS/ECA of cancer(Lecture) B Batch A 13.5.21 THUR (SGD) MI1.11 (LECTURE 16)Immunology of PA 7.3 Carcinogens & FM 9.6- Asphyxiants SGD CM 7.4 demography problems SPORTS/ECA transplantation & Carcinogenesis(Lecture) A Batch B 14.5.21 FRI tumour immunity 15.5.21 SAT 16.5.21 SUN

PA 13.2 13.5 Anticoagulants-Different vaccutainers MI1.6.2 (BATCH A)Antimicrobial PH 1.16.7 - 1.16.10 - susceptibility testing and interpretation PA 7.3 Carcinogens & OSPE-Prepare peripheral blood smear Drugs affecting 5HT – Disk diffusion Demo MI1.7.5 SPORTS/ECA Carcinogenesis(Lecture) and reporting system (L) Slides- Normocytic normochromic Demonstration of types of Antigen blood picture, Eosinophilia(Pracs B) Antibody reactions 17.5.21 MON MI1.6.2 (BATCH B)Antimicrobial susceptibility testing and interpretation FM 10.1 vi- Cardiac PH 1.16.14 - 1.16.23 - PH 3.8 - Drug counselling – Disk diffusion Demo MI1.7.5 SPORTS/ECA Poisons (L) NSAIDs (L) (Batch A) Demonstration of types of Antigen Antibody reactions

18.5.21 TUE MI2.1(LECTURE 17) PA 13.2 13.5 Anticoagulants-Different Rheumatic fever -Microbial vaccutainers CM 11.4 Ergonomics agent and pathogenesis, OSPE-Prepare peripheral blood smear PH 3.8 - Drug counselling SPORTS/ECA (lecture) Lab diagnosis and and reporting (Batch B) management - Slides- Normocytic normochromic 19.5.21 WED Streptococcus pyogenes blood picture, Eosinophilia(Pracs A) PA 9.3 HLA system & PH 1.16.11 - 1.16.13 - FM 11.1- Organic animal immune CM 5.4 Nutrition spotters batch A SPORTS/ECA Migraine (SGD) Irritants SGD B principles(Lecture) 20.5.21 THUR

MI2.2 (LECTURE PA 9.4 Autoimmunity & its FM 11.1- Organic animal CM 7.4 demography problems pandemic module 18)Infective disorders(Lecture) Irritants SGD A Batch B 2.3 endocarditis 21.5.21 FRI IM6.8:- Generate a differential diagnosis and prioritise based on SU2.3 - Communicate and OG6.1 Clinical features clinical features that counsel patients and of pregnancy, MI2.4 (SGD suggest a specific families about the differential diagnosis, SAT 22.5.21 8)Anaemia(1) aetiology for the treatment and prognosis of and the principles aetcom 2.3 presenting symptom shock demonstrating underlying pregnancy IM6.9:- Choose and empathy and care tests interpret appropriate diagnostic tests to 23.5.21 SUN

MI2.1AE (BATCH A)Rheumatic fever - PH 1.16.24 -1.16.27 - PA 7 Formative Streptococci -ASLO MI2.3.1 pandemic module Antirheumatoid drugs PA 9.5 SLE (Lecture) Assesment - Revision Pracs B AE Sepsis markers - CRP, Procalcitonin - 2.3 (L) Neoplasia (SGD) Applied exercise

24.5.21 MON

MI2.1AE (BATCH B)Rheumatic fever - PH 5.1 - Empathy & ethics FM 12.1- Drug Abuse PH 1.17 - Local Anesthetics Streptococci -ASLO MI2.3.1 PH 5.3 - Medication SPORTS/ECA and Addiction (L) (L) AE Sepsis markers - CRP, Procalcitonin - adherence (Batch A) Applied exercise

25.5.21 TUE

CM 11.4 Prevention of PA 7 Formative PH 5.1 - Empathy & ethics MI2.3.1(LECTURE 19) occupational Assesment - Revision Pracs A PH 5.3 - Medication SPORTS/ECA Septicemia hazards(lecture) Neoplasia (SGD) adherence (Batch B) 26.5.21 WED

FM 14.17- Identify & PH 1.16.28 - 1.16.33 - Gout PA 9.6 HIV (Lecture) Draw ML Inference from CM 5.4 Nutrition spotters batch A SPORTS/ECA (SGD) 27.5.21 THUR Common Poisons Pract B MI2.5(LECTURE 20) Parasites endemic to PA 9.7 Common FM 14.17- Identify & pandemic module India- autoimmune disorders Draw ML Inference from CM 5.4 Nutrition spotters batch B 2.3 28.5.21 FRI Classification,distributio (Lecture) Common Poisons Pract A IM6.11:-n and diseases Enumerate burden the (SGD 9)Case indications and OG 7.1 Physiological discussion- describe the findings SU3.1 - Describe the changes in the Hookworms,patho for CT of the chest and Indications and appropriate genital tract, CVS, genesis, clinical SAT brain and MRI use of blood and blood respiratory, 29.5.21 course,lab aetcom 2.4 IM6.13:- Describe and products and complications haematology, renal diagnosis, enumerate the of blood transfusion. and GI system in treatment and indications and side pregnancy prevention effects of drugs for 30.5.21 SUN

PA 9.1 9.2 Principles & mechnism- MI2.2 AE Infective endocarditis- PH 1.15 - Skeletal PA 10.3 Leprosy(Lecture) Immunity, Hypersensitivity(SGD) Pracs (Viridans Streptococci, Coagulase SPORTS/ECA Muscle Relaxants (L) B negative 31.5.21 MON

MI2.2 AE Infective endocarditis- FM 12.1- Drug Abuse PH 1.18.1-1.18.10 - General PH 5.4 - Cost & Compliance (Viridans Streptococci, Coagulase SPORTS/ECA and Addiction (L) Anesthetics (L) (Batch A) negative 1.6.21 TUE MI2.5.1(LECTURE 21) CM 11.5 Hazards of Malaria, mode of infection, PA 9.1 9.2 Principles & mechnism- PH 5.4 - Cost & Compliance Health care worker pathogenesis, clinical Immunity, Hypersensitivity(SGD) Pracs SPORTS/ECA (Batch B) (lecture) course, lab diagnosis, A 2.6.21 WED treatment and prevention

PA 13.3 Anemia - FM 14.5- Conduct and PH 1.18.11 - IV General CM 11.3 occupational health SGD Definition & PM report Preparation SPORTS/ECA Anesthetics (SGD) batch A Classification(Lecture) Pract- B 3.6.21 THUR MI2.5.2(LECTURE 22) Leishmania FM 14.5- Conduct and pathogenesis, clinical Pa 13.4 Investigation of PM report Preparation CM 5.4 Nutrition spotters batch B SPORTS/ECA course, lab Anemia (Lecture) Pract- A diagnosis,treatment 4.6.21 FRI IM6.16:-and prevention Discuss and describe the principles OG8.1 Objectives of (SGD 10) Case of HARRT, the classes of antenatal care, discussion- Malaria antiretrovirals used, SU3.2 - Observe blood assessment of SAT with complication adverse reactions and 5.6.21 transfusions period of gestation; aetcom 2.4 and reinforce life interactions. screening for high- cycle, Babesiosis IM6.17:- Descuss and risk factors describe the principles and regimens used in 6.6.21 SUN

PA 14 Iron Metabolism & PH 1.19.50 - 1.19.57 - Microcytic hypochromic Revision Prac Batch B MI2.4 (BATCH A)stool examination (3) SPORTS/ECA Anti epileptic drugs (L) anemia ( Lecture)

7.6.21 MON

FM13.1-13.2- Environmental PH 1.22 - Drug abuse, PH PH 1.19.15 -1.19.21 - pollution and 5.5 - Drug Dependency MI2.4 (BATCH B)stool examination (3) SPORTS/ECA Antipsychotic drugs (L) Occupational hazards (Batch A) (L) 8.6.21 TUE PH 1.22 - Drug abuse, PH CM 11.2 ESI & Facories MI2.7.1 (LECTURE 23)HIV I Revision prac Batch A 5.5 - Drug Dependency PHARMA -SDL act 9.6.21 WED (Batch B) PA 15.1 , 15.2, 15.4 Vit B12 Metabolism, Deficiency & Lab (SGD) PH 1.19.1 - 1.19.6 - SPORTS/ECA Investigation of Sedatives & Hypnotics Macrocytic THUR 10.6.21 Anemia(Lecture) FM 14.2- Clinical MI2.7.3 (LECTURE 24) PA 16.1 16.2 16.5 Hemolytic Examination and PM Revision prac Batch A SPORTS/ECA HIV 2 anemia (Lecture) report preparation in 11.6.21 FRI case of poisoning Pract B IM6.18:- Enumerate the indications and discuss prophylactic drugs used to prevent HIV related OG8.8 Investigations MI2.5.3 (SGD 1) pportunistic infections. SU3.3 - Counsel patients FM 14.2- Clinical including ultrasound Trypanasomes IM6.22:- Demonstrate and family/ friends for Examination and PM CM 11.3 occupational health SGD in the initial SAT MI2.5.5 SPORTS/ECA 12.6.02 understanding of blood transfusion and report preparation in batch B assessment and Schistosomes ethical and legal issues blood donation. case of poisoning Pract A monitoring in regarding patient pregnancy confidentiality and disclosure in patients with HIV. 13.6.21 SUN

MI2.6 (BATCH A) Demonstration of blood parasites - Plasmodia, PH 1.19.22 - 1.19.26- PA 16.4 Case based discussion - PA 16.3 Sickle cell anemia & Microfilaria (smear)MI2.5.2,3 Antidepressant drugs Hemolytic Anemia- Sickle cell anemia Thalasemia ( Lecture) Demonstration of blood parasites - (L) and thalassemia(SGD) Pracs B Leishmania, Trypanosomes (smear/picture ELISA, PCR 14.6.21 MON MI2.6 (BATCH B) Demonstration of blood parasites - Plasmodia, Ph 1.19.27- 1.19.29 - PH 5.6, 5.7 - OTC & Legal FM 9.2- Inorganic Microfilaria (smear)MI2.5.2,3 Atypical antideppressants aspects of prescribing irritants (L) Demonstration of blood parasites - (L) (Batch A) Leishmania, Trypanosomes (smear/picture ELISA, PCR 15.6.21 TUE

MI2.7.2(SGD 12) PA 16.4 Case based discussion - PH 5.6, 5.7 - OTC & Legal CM 7.7 investigation of Opportunistic infections - Hemolytic Anemia- Sickle cell anemia aspects of prescribing an epidemic (lecture) relevant to HIV/AIDS and thalassemia(SGD) Pracs A (Batch B) 16.6.21 WED FM 14.19- Identify and PA 16.4 Acquired PH 1.19.38 - 1.19.44 - Prepare ML inference Hemolytic Opioid receptors & Revision prac Batch A from Histo-path slides Anemia(Lecture) Morphine (SGD) 17.6.21 THUR Pract B Pathology SDL MI2.7.4(sgd 13) NACO guidelines, strategies, FM 14.19- Identify and pre-test counseling, PA 16.3 Sickle cell anemia & Prepare ML inference post- test counseling Revision prac batch B Thalasemia ( Lecture) from Histo-path slides MI2.7.5 Modes of Pract A transmission,preventio 18.6.21 FRI n 19.6.21 SAT 20.6.21 SUN PA 16.4 Hereditary MI2.7.3(BATCH A) AE Serological PH 1.19.45 - 1.19.49 - spherocytosis & Auto diagnosis of HIV - ICT, MI2.7.3 Complex action opioids immune hemolytic Pre & Posttest counselling, (L) 21.6.21 MON anemia(SGD) Confidentaility (AETCOM - OSPE)

FM 2.31- Demonstration of Team MI2.7.3(BATCH B) AE Serological PH 1.19.30 - 1.19.37 - work for Conduct of ML PH 5.2 - Drug Therapy & diagnosis of HIV - ICT, MI2.7.3 Antimaniac & Autopsies in dowry Storage (Batch A) Pre & Posttest counselling, Psychotomimetic drugs (L) death, Medical Confidentaility (AETCOM - OSPE) 22.6.21 TUE negligence (SGD) MI2.7.2(SGD 10) CM 7.7 investigation of PH 5.2 - Drug Therapy & Opportunistic infections - an epidemic (lecture) Storage (Batch B) 23.6.21 WED relevant to HIV/AIDS 24.6.21 THUR Patho practicsl revision (SGD) 25.6.21 FRI 26.6.21 SAT 27.6.21 SUN Internal Assesment - I Patho/ Micro / Pharmac 28.6.21 MON 29.6.21 TUE 30.6.21 WED

MICR PHARMACOL Pathology OBIO For Med COM MED MEDICNE SURGERY OBG AETCOM OGY LOGY

lecture 35 24 29 14 14 10 10 10 SGD/DOAP/prac 12 36 28 42 28 28 0 0 0 t SDL 3 4 1 5 2 0 0 0